Skip to product information
1 of 2

Invivo Recombinant anti-mouse CD20 antibody

Invivo Recombinant anti-mouse CD20 antibody

Catalog Number: S0B0547 Application: FCM,Functional/Block/Neutralize Reactivity: Mouse Conjugation: Unconjugated Brand: Starter
Price:
Regular price $135.00 USD
Regular price Sale price $135.00 USD
Size:
For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Mouse
Clone Number 18B12
Antibody Type Recombinant mAb
Isotype IgG2a
Isotype Control Invivo mouse IgG2a isotype control
Application FCM, Functional Assay
Reactivity Ms
Purification Protein A
Concentration 5 mg/ml
Purity >95% by SDS-PAGE
Endotoxin <1EU/mg
Physical Appearance Liquid
Storage Buffer

PBS pH7.4, containing no preservative

Stability & Storage

2 to 8 °C for 2 weeks under sterile conditions;

-20 °C for 3 months under sterile conditions; 

-80 °C for 24 months under sterile conditions.

Please avoid repeated freeze-thaw cycles.

Dilution


application dilution species
FCM 1:500

Background

The cluster of differentiation 20 (CD20, aka Ly-44, or B-lymphocyte antigen) is a ~35 KDa cell surface protein mainly expressed by resting and activated B lymphocytes, but not plasma cells [1]. CD20 is also expressed by most malignant B cells, which makes it an ideal target for antibody-based immunotherapies against lymphoid malignancies [1-4]. For example, Rituximab, Obinutuzumab, and Ofatumumab are FDA-approved monoclonal anti-human CD20 antibodies for the treatment of B-cell non-Hodgkin’s lymphoma and B-cell chronic lymphocytic leukemia [1-4]. These antibodies mediate the target cell destruction through different mechanisms including direct signaling of apoptosis, complement activation (CDC), and cell-mediated cytotoxicity (ADCC).

The anti-mCD20 18B12 mAb is commonly used for in vivo depletion of the CD20+ B cell population to study the role of B cells in various immune responses, including auto-immune or tumoral contexts [1, 7].

Anti-mCD20-mIgG2a is provided in an Invivo grade, a high-quality standard specifically adapted to in vivo studies.

Picture

Validation Data

B cell depletion efficacy of S0B0547 in C57 mice

FC

Flow cytometric analysis of mouse primary splenocytes labeling CD20 with purified antibody at 1/500 dilution (1 μg) (Right) compared with a Mouse monoclonal IgG isotype control (Left). Goat Anti-Mouse IgG Alexa Fluor® 488 was used as the secondary antibody. 
Cells were surface stained with CD3-Alexa Fluor® 647, then stained with rabbit IgG (Left) / anti-CD20 (Right) separately. CD3 and CD20 are mutually exclusive expressed in mouse primary splenocytes. Gated on total viable cells.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)